At a glance
- Originator Nonindustrial source
- Class Antibacterials
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 04 Aug 1999 New profile
- 04 Aug 1999 Preclinical development for Bacterial infections in Japan (Unknown route)